kabutan

TRANSGENIC GROUP INC.(2342) Summary

2342
TSE Growth
TRANSGENIC GROUP INC.
271
JPY
-44
(-13.97%)
Dec 5, 11:30 am JST
1.74
USD
Dec 4, 9:30 pm EST
Result
PTS
outside of trading hours
271.9
Dec 5, 11:29 am JST
Summary Chart Historical News Financial Result
PER
112.9
PBR
0.94
Yield
ー%
Margin Trading Ratio
Stock Price
Dec 5, 2025
Opening Dec 5, 9:00 am
320 JPY 2.06 USD
Previous Close Dec 4
315 JPY 2.02 USD
High Dec 5, 9:00 am
325 JPY 2.09 USD
Low Dec 5, 11:22 am
270 JPY 1.74 USD
Volume
2,339,300
Trading Value
0.68B JPY 4.38M USD
VWAP
290.07 JPY 1.87 USD
Minimum Trading Value
27,100 JPY 174 USD
Market Cap
4.61B JPY 0.03B USD
Number of Trades
2,279
Liquidity & Number of Trades
As of Dec 5, 2025
Liquidity
Slightly High
1-Year Average
401
1-Year High Dec 4, 2025
20,104
Margin Trading
Date Short Interest Long Margin Positions Ratio
Nov 28, 2025 114,600 1,605,200 14.01
Nov 21, 2025 400 1,188,400 2971.00
Nov 14, 2025 0 995,200
Nov 7, 2025 0 959,400
Oct 31, 2025 0 962,700
Company Profile
TRANSGENIC GROUP INC. is a biotech venture supporting drug discovery research. The company specializes in genetic analysis using mice and is expanding through succession-based M&A.
Sector
Services
TRANSGENIC GROUP INC. operates two main business segments: drug discovery support and investment/consulting. In the drug discovery support segment, the company offers services such as genetically modified mouse production, antibody production, glycan analysis and synthesis, preclinical trials, and clinical trial outsourcing. The investment and consulting segment focuses on promoting new businesses through M&A and supporting business succession and revitalization. This segment includes various activities such as the sale of electrical products, import and sale of Western tableware, development and sale of information and communication equipment, import and sale of auxiliary materials for multi-layered glass and glass processing equipment, and import and sale of printer toners.